REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-05-28 |
|---|---|---|---|---|
| 2026 | $482.66 | $402.9 | $588.48 | -22.34% |
| 2027 | $414.98 | $397.72 | $427.33 | -33.23% |
| 2028 | $347.19 | $307.89 | $402.29 | -44.14% |
| 2029 | $313.05 | $308.74 | $317.11 | -49.63% |
| 2030 | $311.81 | $307.23 | $320.38 | -49.83% |
| 2031 | $320.92 | $318.64 | $323.32 | -48.36% |
| 2032 | $337.58 | $320.7 | $367.49 | -45.68% |
| 2033 | $644.31 | $375.55 | $1426.5 | 3.67% |
| 2034 | $5121.32 | $2115.18 | $6129.23 | 724.0% |
| 2035 | $6120.89 | $5480.61 | $6638.75 | 884.83% |
| 2036 | $4292.03 | $3423.31 | $5160.49 | 590.57% |
The 32 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$827.47 with a high forecast of $995.0 and a low forecast of $641.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 33.14%
increase from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast for 2026, 7 predictions are offered for each month of 2026 with average REGENERON PHARMACEUTICALS stock
forecast of $482.66, a high forecast of $588.48, and a low forecast of $402.9.
The average REGENERON PHARMACEUTICALS stock forecast 2026 represents a -22.34%
decrease from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast for 2027, 12 predictions are offered for each month of 2027 with average REGENERON PHARMACEUTICALS stock
forecast of $414.98, a high forecast of $427.33, and a low forecast of $397.72.
The average REGENERON PHARMACEUTICALS stock forecast 2027 represents a -33.23%
decrease from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast for 2029, 12 predictions are offered for each month of 2029 with average REGENERON PHARMACEUTICALS stock
forecast of $313.05, a high forecast of $317.11, and a low forecast of $308.74.
The average REGENERON PHARMACEUTICALS stock forecast 2029 represents a -49.63%
decrease from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average REGENERON PHARMACEUTICALS stock
forecast of $320.92, a high forecast of $323.32, and a low forecast of $318.64.
The average REGENERON PHARMACEUTICALS stock forecast 2031 represents a -48.36%
decrease from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast 2032, 12 predictions are offered for each month of 2032 with average REGENERON PHARMACEUTICALS stock
forecast of $337.58, a high forecast of $367.49, and a low forecast of $320.7.
The average REGENERON PHARMACEUTICALS stock forecast 2032 represents a -45.68%
decrease from the last price of $621.52001953125.
For REGENERON PHARMACEUTICALS stock forecast for 2036 (10 year), 5 predictions are offered for each month of 2036 with average REGENERON PHARMACEUTICALS stock
forecast of $4292.03, a high forecast of $5160.49, and a low forecast of $3423.31.
The average REGENERON PHARMACEUTICALS stock forecast 2036 represents a 590.57%
increase from the last price of $621.52001953125.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $827.47, and this show a -0.42% decrease in average from the prior price target of the each prediction. Also, this average forecast of $827.47 represents a 8.41% increase from the past average forecast of $763.3, 6 months ago from 30 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2026-05-19 | Canaccord Genuity | $1057.00 | $875.0000 | Buy |
| 2026-05-18 | BMO Capital | $900.0000 | $730.0000 | Outperform |
| 2026-05-18 | Truist Securities | $796.00 | $778.0000 | Buy |
| 2026-05-18 | JP Morgan | $950.00 | $850.0000 | Overweight |
| 2026-05-18 | Piper Sandler | $875.00 | $855.0000 | Overweight |
| 2026-05-18 | Wells Fargo | $800.0000 | $700.0000 | Equal-Weight |
| 2026-05-18 | RBC Capital | $762.0000 | $707.0000 | Sector Perform |
| 2026-05-18 | Citigroup | $900.0000 | $700.0000 | Neutral |
| 2026-05-18 | Leerink Partners | $792.0000 | $641.0000 | Market Perform |
| 2026-05-01 | Guggenheim | $975.00 | $995.0000 | Buy |
| 2026-04-30 | RBC Capital | $779.0000 | $762.0000 | Sector Perform |
| 2026-04-30 | Barclays | $923.00 | $917.0000 | Overweight |
| 2026-04-30 | Truist Securities | $801.00 | $796.0000 | Buy |
| 2026-04-30 | Wells Fargo | $825.0000 | $800.0000 | Equal-Weight |
| 2026-04-23 | TD Cowen | $880.0000 | $960.0000 | Buy |
| 2026-04-23 | Cantor Fitzgerald | $800.00 | $800.0000 | Overweight |
| 2026-04-10 | Morgan Stanley | $769.00 | $796.0000 | Equal-Weight |
| 2026-04-08 | Bernstein | $925.0000 | $921.0000 | Outperform |
| 2026-03-31 | Piper Sandler | $875.0000 | Overweight | |
| 2026-03-31 | Truist Securities | $818.00 | $801.0000 | Buy |
| 2026-03-06 | Barclays | $923.0000 | Overweight | |
| 2026-03-02 | RBC Capital | $745.0000 | $765.0000 | Sector Perform |
| 2026-02-09 | Guggenheim | $865.00 | $975.0000 | Buy |
| 2026-02-02 | JP Morgan | $850.0000 | $950.0000 | Overweight |
| 2026-02-02 | Oppenheimer | $750.0000 | $865.0000 | Outperform |
| 2026-02-02 | Morgan Stanley | $768.00 | $769.0000 | Equal-Weight |
| 2026-02-02 | Wells Fargo | $745.00 | $800 | Equal-Weight |
| 2026-02-02 | Cantor Fitzgerald | $740.0000 | $800.0000 | Overweight |
| 2026-02-02 | Truist Securities | $820.00 | $818 | Buy |
| 2026-01-22 | Evercore ISI Group | $750.0000 | $875.0000 | Outperform |
| 2026-01-08 | Truist Securities | $798.00 | $820.0000 | Buy |
| 2026-01-07 | B of A Securities | $627.00 | $860.0000 | Buy |
| 2025-12-12 | Morgan Stanley | $767.00 | $768.0000 | Equal-Weight |
| 2025-12-10 | Wells Fargo | $700.0000 | $745.0000 | Equal-Weight |
| 2025-12-04 | Canaccord Genuity | $850.00 | $1057 | Buy |
| 2025-12-04 | BMO Capital | $725.0000 | $850.0000 | Outperform |
| 2025-12-03 | Morgan Stanley | $767.0000 | $767.0000 | Equal-Weight |
| 2025-11-24 | Truist Securities | $812.0000 | $798.0000 | Buy |
| 2025-11-24 | Scotiabank | $650.0000 | $770.0000 | Sector Perform |
| 2025-11-24 | HSBC | $890.0000 | Buy | |
| 2025-11-20 | Wells Fargo | $615.0000 | $700.0000 | Equal-Weight |
| 2025-11-07 | UBS | $595.0000 | $660.0000 | Neutral |
| 2025-10-29 | Guggenheim | $815.00 | $865.0000 | Buy |
| 2025-10-29 | Cantor Fitzgerald | $678.0000 | $740.0000 | Overweight |
| 2025-10-29 | Wells Fargo | $580.0000 | $615.0000 | Equal-Weight |
| 2025-10-29 | RBC Capital | $704.0000 | $708.0000 | Sector Perform |
| 2025-10-29 | Citigroup | $660.00 | $700.0000 | Buy |
| 2025-10-29 | B of A Securities | $543.0000 | $627.0000 | Underperform |
| 2025-10-23 | Canaccord Genuity | $850.0000 | $850 | Buy |
| 2025-10-14 | Canaccord Genuity | $850.00 | $850.00 | Buy |
| 2025-10-13 | Citigroup | $650.00 | $660.0000 | Buy |
| 2025-10-10 | Morgan Stanley | $761.00 | $756.0000 | Overweight |
| 2025-08-27 | Jefferies | $813.0000 | $831 | Buy |
| 2025-08-27 | Bernstein | $753.0000 | $781.0000 | Outperform |
| 2025-08-11 | Truist Securities | $940.00 | $812 | Buy |
| 2025-08-04 | Guggenheim | $810.0000 | $815.0000 | Buy |
| 2025-08-04 | RBC Capital | $688.0000 | $695.0000 | Sector Perform |
| 2025-08-04 | Morgan Stanley | $754.00 | $761 | Overweight |
| 2025-08-04 | BMO Capital | $600.00 | $640 | Outperform |
| 2025-07-23 | Canaccord Genuity | $850.00 | $850.00 | Buy |
| 2025-07-11 | UBS | $560.00 | $584.0000 | Neutral |
| 2025-07-10 | Morgan Stanley | $755.0000 | $754 | Overweight |
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-05-29 | $632.78 | 1.81% |
| 2026-06-01 | $645.40 | 1.99% |
| 2026-06-02 | $653.69 | 1.28% |
| 2026-06-03 | $659.42 | 0.88% |
| 2026-06-04 | $670.06 | 1.61% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Jun. is $588.48 , for 2027 May. is $416.28 , for 2030 May. is $307.43 , for 2031 May. is $318.72 , for 2035 May. is $6113.84 , and for 2036 May. is $3423.31.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jun. | $588.48 | -5.32% |
| 2026 Jul. | $548.10 | -6.86% |
| 2026 Aug. | $508.63 | -7.20% |
| 2026 Sep. | $471.86 | -7.23% |
| 2026 Oct. | $441.21 | -6.50% |
| 2026 Nov. | $417.45 | -5.38% |
| 2026 Dec. | $402.90 | -3.49% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $397.72 | -1.29% |
| 2027 Feb. | $399.16 | 0.36% |
| 2027 Mar. | $404.40 | 1.31% |
| 2027 Apr. | $410.80 | 1.58% |
| 2027 May. | $416.28 | 1.33% |
| 2027 Jun. | $421.11 | 1.16% |
| 2027 Jul. | $425.25 | 0.98% |
| 2027 Aug. | $427.33 | 0.49% |
| 2027 Sep. | $426.95 | -0.09% |
| 2027 Oct. | $423.14 | -0.89% |
| 2027 Nov. | $417.30 | -1.38% |
| 2027 Dec. | $410.30 | -1.68% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $402.29 | -1.95% |
| 2028 Feb. | $393.00 | -2.31% |
| 2028 Mar. | $382.35 | -2.71% |
| 2028 Apr. | $371.07 | -2.95% |
| 2028 May. | $358.45 | -3.40% |
| 2028 Jun. | $346.36 | -3.37% |
| 2028 Jul. | $336.00 | -2.99% |
| 2028 Aug. | $327.57 | -2.51% |
| 2028 Sep. | $319.46 | -2.48% |
| 2028 Oct. | $312.81 | -2.08% |
| 2028 Nov. | $308.99 | -1.22% |
| 2028 Dec. | $307.89 | -0.36% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $309.25 | 0.44% |
| 2029 Feb. | $311.31 | 0.67% |
| 2029 Mar. | $313.64 | 0.75% |
| 2029 Apr. | $316.59 | 0.94% |
| 2029 May. | $317.11 | 0.16% |
| 2029 Jun. | $316.83 | -0.09% |
| 2029 Jul. | $315.63 | -0.38% |
| 2029 Aug. | $314.34 | -0.41% |
| 2029 Sep. | $312.73 | -0.51% |
| 2029 Oct. | $310.91 | -0.58% |
| 2029 Nov. | $309.47 | -0.46% |
| 2029 Dec. | $308.74 | -0.24% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $308.40 | -0.11% |
| 2030 Feb. | $307.98 | -0.14% |
| 2030 Mar. | $307.51 | -0.15% |
| 2030 Apr. | $307.23 | -0.09% |
| 2030 May. | $307.43 | 0.07% |
| 2030 Jun. | $308.34 | 0.29% |
| 2030 Jul. | $310.03 | 0.55% |
| 2030 Aug. | $312.39 | 0.76% |
| 2030 Sep. | $315.05 | 0.85% |
| 2030 Oct. | $317.56 | 0.80% |
| 2030 Nov. | $319.41 | 0.59% |
| 2030 Dec. | $320.38 | 0.30% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $320.49 | 0.03% |
| 2031 Feb. | $319.98 | -0.16% |
| 2031 Mar. | $319.20 | -0.24% |
| 2031 Apr. | $318.64 | -0.18% |
| 2031 May. | $318.72 | 0.02% |
| 2031 Jun. | $319.63 | 0.28% |
| 2031 Jul. | $321.09 | 0.46% |
| 2031 Aug. | $322.52 | 0.45% |
| 2031 Sep. | $323.32 | 0.25% |
| 2031 Oct. | $323.28 | -0.01% |
| 2031 Nov. | $322.59 | -0.21% |
| 2031 Dec. | $321.63 | -0.30% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $320.83 | -0.25% |
| 2032 Feb. | $320.70 | -0.04% |
| 2032 Mar. | $321.57 | 0.27% |
| 2032 Apr. | $323.52 | 0.61% |
| 2032 May. | $326.56 | 0.94% |
| 2032 Jun. | $330.63 | 1.25% |
| 2032 Jul. | $335.65 | 1.52% |
| 2032 Aug. | $341.46 | 1.73% |
| 2032 Sep. | $347.72 | 1.83% |
| 2032 Oct. | $354.14 | 1.85% |
| 2032 Nov. | $360.68 | 1.85% |
| 2032 Dec. | $367.49 | 1.89% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $375.55 | 2.19% |
| 2033 Feb. | $386.08 | 2.80% |
| 2033 Mar. | $400.64 | 3.77% |
| 2033 Apr. | $420.91 | 5.06% |
| 2033 May. | $449.08 | 6.69% |
| 2033 Jun. | $488.11 | 8.69% |
| 2033 Jul. | $541.58 | 10.96% |
| 2033 Aug. | $613.70 | 13.32% |
| 2033 Sep. | $712.83 | 16.15% |
| 2033 Oct. | $853.91 | 19.79% |
| 2033 Nov. | $1062.80 | 24.46% |
| 2033 Dec. | $1426.50 | 34.22% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $2115.18 | 48.28% |
| 2034 Feb. | $3214.42 | 51.97% |
| 2034 Mar. | $4427.28 | 37.73% |
| 2034 Apr. | $4987.30 | 12.65% |
| 2034 May. | $5177.73 | 3.82% |
| 2034 Jun. | $5524.47 | 6.70% |
| 2034 Jul. | $5805.26 | 5.08% |
| 2034 Aug. | $5936.40 | 2.26% |
| 2034 Sep. | $5998.44 | 1.05% |
| 2034 Oct. | $6044.64 | 0.77% |
| 2034 Nov. | $6095.46 | 0.84% |
| 2034 Dec. | $6129.23 | 0.55% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $6137.88 | 0.14% |
| 2035 Feb. | $6018.37 | -1.95% |
| 2035 Mar. | $5833.67 | -3.07% |
| 2035 Apr. | $5793.97 | -0.68% |
| 2035 May. | $6113.84 | 5.52% |
| 2035 Jun. | $6539.34 | 6.96% |
| 2035 Jul. | $6638.75 | 1.52% |
| 2035 Aug. | $6559.14 | -1.20% |
| 2035 Sep. | $6401.09 | -2.41% |
| 2035 Oct. | $6124.22 | -4.33% |
| 2035 Nov. | $5809.75 | -5.13% |
| 2035 Dec. | $5480.61 | -5.67% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $5160.49 | -5.84% |
| 2036 Feb. | $4766.74 | -7.63% |
| 2036 Mar. | $4293.96 | -9.92% |
| 2036 Apr. | $3815.65 | -11.14% |
| 2036 May. | $3423.31 | -10.28% |
Financial Data for REGENERON PHARMACEUTICALS stock
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2026 Jun. is $588.4802869255844 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2027 May. is $416.27876815371667 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2030 May. is $307.43407821801065 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2031 May. is $318.7212964029482 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2035 May. is $6113.841082244403 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to AIPickup, the REGENERON PHARMACEUTICALS stock price forecast for 2036 May. is $3423.3143729020894
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go DOWN . Therefore, AIPickup would say that REGENERON PHARMACEUTICALS (REGN) stock is overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
No. The REGENERON PHARMACEUTICALS stock price forecast for 2027 May. is $416.27876815371667
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2026-05-28 is $621.52001953125 and forecast for 2027 May. is $416.28, REGENERON PHARMACEUTICALS stock is not a good 1 year investment.
14 Days Historical Data for REGENERON PHARMACEUTICALS stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| REGN stock price for 2026-05-08 | $713.82 | $708.23 | $707.30 | $716.92 |
| REGN stock price for 2026-05-11 | $711.71 | $713.92 | $700.94 | $726.31 |
| REGN stock price for 2026-05-12 | $722.33 | $715.32 | $708.96 | $724.52 |
| REGN stock price for 2026-05-13 | $718.81 | $720.21 | $708.45 | $729.50 |
| REGN stock price for 2026-05-14 | $711.81 | $717.93 | $709.00 | $721.43 |
| REGN stock price for 2026-05-15 | $697.21 | $711.63 | $692.67 | $716.82 |
| REGN stock price for 2026-05-18 | $628.74 | $615.01 | $609.69 | $632.06 |
| REGN stock price for 2026-05-19 | $629.36 | $629.55 | $615.10 | $639.04 |
| REGN stock price for 2026-05-20 | $649.76 | $634.32 | $633.60 | $651.00 |
| REGN stock price for 2026-05-21 | $642.59 | $645.00 | $639.81 | $650.32 |
| REGN stock price for 2026-05-22 | $638.88 | $639.24 | $632.72 | $644.12 |
| REGN stock price for 2026-05-26 | $634.62 | $642.45 | $632.68 | $648.50 |
| REGN stock price for 2026-05-27 | $627.74 | $634.80 | $625.00 | $638.06 |
| REGN stock price for 2026-05-28 | $621.52 | $630.15 | $620.35 | $631.73 |